Form 8-K - Current report:
SEC Accession No. 0000950170-25-088482
Filing Date
2025-06-20
Accepted
2025-06-20 16:03:02
Documents
10
Period of Report
2025-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K fdmt-20250617.htm   iXBRL 8-K 80677
  Complete submission text file 0000950170-25-088482.txt   192033

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fdmt-20250617.xsd EX-101.SCH 26082
12 EXTRACTED XBRL INSTANCE DOCUMENT fdmt-20250617_htm.xml XML 4932
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39782 | Film No.: 251061256
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)